Literature DB >> 4396307

Risks of smallpox vaccination complications in the United States.

J M Lane, J D Millar.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4396307     DOI： 10.1093/oxfordjournals.aje.a121252

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  12 in total

1.  Uncertain benefit: the public policy of approving smallpox vaccine research.

Authors:  Rosemary B Quigley
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

2.  Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.

Authors:  Janice Elaine Y Silverman; Mihai Ciustea; Abigail M Druck Shudofsky; Florent Bender; Robert H Shoemaker; Robert P Ricciardi
Journal:  Antiviral Res       Date:  2008-06-20       Impact factor: 5.970

3.  Change in smallpox vaccination policy.

Authors: 
Journal:  Calif Med       Date:  1972-03

Review 4.  The smallpox story: life and death of an old disease.

Authors:  A M Behbehani
Journal:  Microbiol Rev       Date:  1983-12

Review 5.  Smallpox vaccine: the good, the bad, and the ugly.

Authors:  Edward A Belongia; Allison L Naleway
Journal:  Clin Med Res       Date:  2003-04

Review 6.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

7.  Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion.

Authors:  Luzheng Liu; Zhan Xu; Robert C Fuhlbrigge; Victor Peña-Cruz; Judy Lieberman; Thomas S Kupper
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.

Authors:  R C Dunlap; L F Barker
Journal:  Arch Gesamte Virusforsch       Date:  1973

10.  Progressive vaccinia: immunological aspects and transfer factor therapy.

Authors:  L Timár; J Budai; G Nyerges; R Szigeti; I Hollós; I Sonkoly
Journal:  Infection       Date:  1978       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.